Nurs 323 Pharm Quiz 1 Practice Questions With
Correct Answers
Place the following routes of medication administration in order of most
| | | | | | | | | | |
bioavailable to least bioavailable: IM/SQ, PO, IV - CORRECT ANSWER✔✔-Most: IV
| | | | | | | | | |
IM/SQ
Least: PO |
Which drug needs special transport across a cell membrane in order to be
| | | | | | | | | | | | |
effective?
a) Lipid soluble meds and ionized
| | | | |
b) Water soluble meds and non-ionized - CORRECT ANSWER✔✔-b) Water soluble
| | | | | | | | | | |
meds and non-ionized | |
Mr. Jones is taking drug A which is metabolized by the CYP3A4 enzyme in the
| | | | | | | | | | | | | | |
liver. He loves to drink grapefruit juice which is a known inhibitor of that enzyme.
| | | | | | | | | | | | | | |
If this inhibits the enzyme, will the patient have higher levels of the drug in the
| | | | | | | | | | | | | | | |
body or lower levels of the drug? - CORRECT ANSWER✔✔-Higher levels of the
| | | | | | | | | | | | |
drug
Mrs. Smith is taking drug C which is metabolized by the CYP3A4 enzyme in the
| | | | | | | | | | | | | | |
liver. She just started on drug D which is a known inducer of that enzyme. If this
| | | | | | | | | | | | | | | | |
induces the enzyme, will the patient have higher levels of drug C in the body or
| | | | | | | | | | | | | | | |
, lower levels of drug C in the body? - CORRECT ANSWER✔✔-Lower levels of drug
| | | | | | | | | | | | | |
C
Drug X has a narrow therapeutic range of 1-3. What does that mean for safety
| | | | | | | | | | | | | | |
implications? - CORRECT ANSWER✔✔-Less safe | | | |
Drug H has a half life of 2 days. When a patient starts taking this medication it will
| | | | | | | | | | | | | | | | |
take _____ to _____ days to reach plateau. - CORRECT ANSWER✔✔-8 to 10
| | | | | | | | | | | | |
Providers may prescribe loading and maintenance doses of some drugs to achieve
| | | | | | | | | | |
plateau faster. The nurse knows the loading dose will be _____ and the
| | | | | | | | | | | | | |
maintenance dose will be _____. (Lower or higher) - CORRECT ANSWER✔✔-
| | | | | | | | | |
Loading dose will be higher and the maintenance dose will be lower.
| | | | | | | | | | |
Drug Y mimics the action of endogenous hormone T filling the receptors which
| | | | | | | | | | | | |
makes it a(n): | |
a) Agonist
|
b) Antagonist - CORRECT ANSWER✔✔-a) Agonist
| | | | |
If an antagonist is constantly blocking a receptor, does that make the receptor
| | | | | | | | | | | | |
more or less sensitive when it is eventually filled by the agonist? - CORRECT
| | | | | | | | | | | | | |
ANSWER✔✔-More sensitive |
A patient has been taking a brand-name drug, which is now being changed to
| | | | | | | | | | | | | |
generic. The patient asks the nurse if he should pay out of his pocket to continue
| | | | | | | | | | | | | | | |
receiving the brand name drug. Your response is:
| | | | | | |
Correct Answers
Place the following routes of medication administration in order of most
| | | | | | | | | | |
bioavailable to least bioavailable: IM/SQ, PO, IV - CORRECT ANSWER✔✔-Most: IV
| | | | | | | | | |
IM/SQ
Least: PO |
Which drug needs special transport across a cell membrane in order to be
| | | | | | | | | | | | |
effective?
a) Lipid soluble meds and ionized
| | | | |
b) Water soluble meds and non-ionized - CORRECT ANSWER✔✔-b) Water soluble
| | | | | | | | | | |
meds and non-ionized | |
Mr. Jones is taking drug A which is metabolized by the CYP3A4 enzyme in the
| | | | | | | | | | | | | | |
liver. He loves to drink grapefruit juice which is a known inhibitor of that enzyme.
| | | | | | | | | | | | | | |
If this inhibits the enzyme, will the patient have higher levels of the drug in the
| | | | | | | | | | | | | | | |
body or lower levels of the drug? - CORRECT ANSWER✔✔-Higher levels of the
| | | | | | | | | | | | |
drug
Mrs. Smith is taking drug C which is metabolized by the CYP3A4 enzyme in the
| | | | | | | | | | | | | | |
liver. She just started on drug D which is a known inducer of that enzyme. If this
| | | | | | | | | | | | | | | | |
induces the enzyme, will the patient have higher levels of drug C in the body or
| | | | | | | | | | | | | | | |
, lower levels of drug C in the body? - CORRECT ANSWER✔✔-Lower levels of drug
| | | | | | | | | | | | | |
C
Drug X has a narrow therapeutic range of 1-3. What does that mean for safety
| | | | | | | | | | | | | | |
implications? - CORRECT ANSWER✔✔-Less safe | | | |
Drug H has a half life of 2 days. When a patient starts taking this medication it will
| | | | | | | | | | | | | | | | |
take _____ to _____ days to reach plateau. - CORRECT ANSWER✔✔-8 to 10
| | | | | | | | | | | | |
Providers may prescribe loading and maintenance doses of some drugs to achieve
| | | | | | | | | | |
plateau faster. The nurse knows the loading dose will be _____ and the
| | | | | | | | | | | | | |
maintenance dose will be _____. (Lower or higher) - CORRECT ANSWER✔✔-
| | | | | | | | | |
Loading dose will be higher and the maintenance dose will be lower.
| | | | | | | | | | |
Drug Y mimics the action of endogenous hormone T filling the receptors which
| | | | | | | | | | | | |
makes it a(n): | |
a) Agonist
|
b) Antagonist - CORRECT ANSWER✔✔-a) Agonist
| | | | |
If an antagonist is constantly blocking a receptor, does that make the receptor
| | | | | | | | | | | | |
more or less sensitive when it is eventually filled by the agonist? - CORRECT
| | | | | | | | | | | | | |
ANSWER✔✔-More sensitive |
A patient has been taking a brand-name drug, which is now being changed to
| | | | | | | | | | | | | |
generic. The patient asks the nurse if he should pay out of his pocket to continue
| | | | | | | | | | | | | | | |
receiving the brand name drug. Your response is:
| | | | | | |
